Following administration of a dose of 850 mg, the plasma peak concentration was 40% lower, AUC was decreased by 25% and time to peak plasma concentration was prolonged by 35 minutes.
Pärast 850 mg annuse manustamist täheldati maksimaalse plasmakontsentratsiooni 40% langust, AUC 25% vähenemist ja maksimaalse plasmakontsentratsiooni saabumise aja pikenemist 35 minuti võrra.